Dr. Xingde Li is a professor of biomedical engineering at the Johns Hopkins University School of Medicine and a member of the Johns Hopkins Kimmel Cancer Center. He also has an appointment in the Department of Oncology and the Johns Hopkins University Department of Electrical and Computer Engineering.
His research focuses on biomedical photonics, and he has specific expertise in fluorescence imaging and spectroscopy, optical coherence tomography (OCT), and multiphoton endomicroscopy for cancer detection, surgical guidance, and preterm-birth risk assessment etc. His research group pioneered the development of the first ultra-compact, fully integrated, single-fiber scanning endomicroscope for performing label-free functional imaging of tissue histology in vivo, in situ, and in real time. The ultimate goal of the research in his team is to transform our capability of disease detection at early, manageable stages, reduction of the (random) sampling errors in clinical diagnosis, monitoring of therapeutic effects and treatment outcomes, and guidance of interventions. The technologies developed in his team also offer new opportunities for basic research in exploring new frontiers of disease mechanisms, brain function, bio-marker discovery, and integrated diagnosis and therapy.
Dr. Li received his undergraduate degree in physics from the University of Science and Technology of China (USTC). He earned his Ph.D. from the University of Pennsylvania. He completed postdoctoral training in biomedical optics at the Massachusetts Institute of Technology. Dr. Li joined the Johns Hopkins faculty in 2009.
Prior to joining Johns Hopkins, Dr. Li was an associate professor of bioengineering at the University of Washington.
He serves on the editorial board of several journals, including the Journal of Biomedical Optics, Biomedical Optics Express, IEEE Transactions on Biomedical Engineering, and Light: Science and Applications. His work has been recognized with several awards, including the ADR/GlaxoSmithKline Innovation in Oral Care Award in 2009.